Dr. Sam Parnia, MD, PhD
Claim this profileNYU Langone Health
Studies Cardiac Arrest
Studies Heart Attack
5 reported clinical trials
10 drugs studied
Affiliated Hospitals
Clinical Trials Sam Parnia, MD, PhD is currently running
Magnesium
for Cardiac Arrest
The purpose of this pilot interventional study is to collect preliminary data on administering magnesium sulfate as a neuroprotective medication in patients who achieved Return of Spontaneous Circulation (ROSC) following Cardiac Arrest (CA). The primary aims are to assess the feasibility and safety of administering magnesium and measure serum markers of neuronal injury at prespecified time points in the post-cardiac arrest period. Because this is a pilot study with a limited sample size, the primary objective is to evaluate the precision and stability of the collected measures to inform the design and formal analysis in a larger trial.
Recruiting0 awards Phase 1
Red Blood Cell Transfusion
for Cardiac Arrest
The purpose of this pilot interventional study is to collect preliminary data on administering packed red blood cell (PRBC) during cardiac arrest (CA). The primary objective is to assess the feasibility of PRBC transfusion during cardiac CA to help optimize the methods required to augment cerebral and other vital organ oxygen delivery during cardiopulmonary resuscitation (CPR). The secondary objectives are to assess the effect of PRBC transfusion during prolonged cardiac arrests on cerebral oxygenation, end tidal carbon dioxide (ETCO2), return of spontaneous circulation (ROSC), survival to discharge, biomarkers of neural injury and inflammation, and neurological outcomes at hospital discharge, 30 days post-CA, and 90 days post-CA.
Recruiting0 awards Phase 12 criteria
More about Sam Parnia, MD, PhD
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Sam Parnia, MD, PhD has experience with
- Magnesium Sulfate
- Packed Red Blood Cells
- Non-Physiological Feedback CPR
- Physiological Feedback CPR
- Abatacept
- Cenicriviroc
Breakdown of trials Sam Parnia, MD, PhD has run
Ischemia Reperfusion Injury
Reperfusion Injury
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sam Parnia, MD, PhD specialize in?
Sam Parnia, MD, PhD focuses on Cardiac Arrest and Heart Attack. In particular, much of their work with Cardiac Arrest has involved treating patients, or patients who are undergoing treatment.
Is Sam Parnia, MD, PhD currently recruiting for clinical trials?
Yes, Sam Parnia, MD, PhD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Sam Parnia, MD, PhD has studied deeply?
Yes, Sam Parnia, MD, PhD has studied treatments such as Magnesium Sulfate, Packed Red Blood Cells, Non-Physiological Feedback CPR.
What is the best way to schedule an appointment with Sam Parnia, MD, PhD?
Apply for one of the trials that Sam Parnia, MD, PhD is conducting.
What is the office address of Sam Parnia, MD, PhD?
The office of Sam Parnia, MD, PhD is located at: NYU Langone Health, New York, New York 10016 United States. This is the address for their practice at the NYU Langone Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.